Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

63850 1504871583HCLSReviewHongKongSeptember2017.pdf
Energy Boardroom

Leading Pfizer and AstraZeneca shareholder BlackRock wants the megamerger

23.05.2014 / Fierce Pharma

Four times Pfizer has made offers to buy AstraZeneca and four times, the U.K. company has said no. But the world's largest money-management firm hopes in this case no doesn't mean no. BlackRock–which owns 8% of AstraZeneca and 6.8% of Pfizer–is encouraging discussions between the two companies, according to Bloomberg, which cited anonymous sources.

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: